BRO vs SER · P/E 30, rev $4.80B vs rev $56.0K
Brown & Brown Inc (BRO) versus Serina Therapeutics Inc (SER) — a side-by-side from cached financials, not a winner call.
Brown & Brown Inc (BRO) is a insurance brokers company listed on US.
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
Latest reported BRO revenue for 2024-12-31 was $4.80B. Net income was $1.00B. Revenue was up 12.9% from 2023-12-31 to 2024-12-31. BRO currently screens at market cap $35.56B and trailing P/E 30.0.
Latest reported SER revenue for 2024-12-31 was $56.0K. Net income was -$11.2M. Revenue was down 98.2% from 2023-12-31 to 2024-12-31. SER currently screens at market cap $29.7M.
BRO currently screens at market cap $35.56B and trailing P/E 30.0. SER currently screens at market cap $29.7M.
Not investment advice. Open the BRO and SER stock pages for the full models.
Not investment advice.